Abstract
During the last decade the nanotechnologists began research on applications of nanomaterials for medicine and therapeutics. Various nanoparticles (nanomedicines) are being used worldwide for the diagnosis and management in a number of disorders including cancer and neurodegenerative disorders. The successful non-viral gene therapy is now possible with the advancements in nanotechnology. Mostly nanoparticles are divided into two main classes: organic and inorganic nanoparticles. Diverse features of nanomedicines with surface modification help to make them biocompatible with addition of varying polymer that facilitates targeted delivery of drug and its controlled release into the cells, tissues and organs. Liposomes, quantum dots, silver and gold nanoparticles are the most common examples of nanomedicines.
Keywords: Cancer, gene therapy¸ liposomes, nanomedicines, neurodegenerative disorders, quantum dots, silver and gold nanoparticles.
Current Drug Metabolism
Title:Recent Developments in Nanomedicines for Management of Various Health Issues Via Metabolism and Physico-Chemical Properties
Volume: 16 Issue: 5
Author(s): Mahmood Rasool, Muhammad Imran Naseer, Arif Malik, Abdul Manan, Ikram Ullah, Noman Bin Abid, Myeong Ok Kim, Mahmood Husain Qazi, Mohammad Amjad Kamal and Fehmida Bibi
Affiliation:
Keywords: Cancer, gene therapy¸ liposomes, nanomedicines, neurodegenerative disorders, quantum dots, silver and gold nanoparticles.
Abstract: During the last decade the nanotechnologists began research on applications of nanomaterials for medicine and therapeutics. Various nanoparticles (nanomedicines) are being used worldwide for the diagnosis and management in a number of disorders including cancer and neurodegenerative disorders. The successful non-viral gene therapy is now possible with the advancements in nanotechnology. Mostly nanoparticles are divided into two main classes: organic and inorganic nanoparticles. Diverse features of nanomedicines with surface modification help to make them biocompatible with addition of varying polymer that facilitates targeted delivery of drug and its controlled release into the cells, tissues and organs. Liposomes, quantum dots, silver and gold nanoparticles are the most common examples of nanomedicines.
Export Options
About this article
Cite this article as:
Rasool Mahmood, Imran Naseer Muhammad, Malik Arif, Manan Abdul, Ullah Ikram, Bin Abid Noman, Ok Kim Myeong, Husain Qazi Mahmood, Amjad Kamal Mohammad and Bibi Fehmida, Recent Developments in Nanomedicines for Management of Various Health Issues Via Metabolism and Physico-Chemical Properties, Current Drug Metabolism 2015; 16 (5) . https://dx.doi.org/10.2174/1389200215666141125121211
DOI https://dx.doi.org/10.2174/1389200215666141125121211 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Disease-Induced Neuroinflammation and Depression
CNS & Neurological Disorders - Drug Targets Review of Theoretical Studies for Prediction of Neurodegenerative Inhibitors
Mini-Reviews in Medicinal Chemistry The gp130 Receptor Cytokine Family: Regulators of Adipocyte Development and Function
Current Pharmaceutical Design Subject Index To Volume 1
Recent Patents on CNS Drug Discovery (Discontinued) Tetracyclines and Pulmonary Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Metabolic Stress and Inflammation: Implication in Treatment for Neurological Disorders
CNS & Neurological Disorders - Drug Targets Endocannabinoid System in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Plasma Angiotensin-(1-7) is a Potential Biomarker for Alzheimer’s Disease
Current Neurovascular Research The Neuroinflammatory Response in Plaques and Amyloid Angiopathy in Alzheimers Disease: Therapeutic Implications
Current Drug Targets - CNS & Neurological Disorders Survival Signaling Pathways Activated by NMDA Receptors
Current Topics in Medicinal Chemistry The Heat Shock Connection of Metabolic Stress and Dietary Restriction
Current Pharmaceutical Biotechnology Lentiviral Transgenesis - A Versatile Tool for Basic Research and Gene Therapy
Current Gene Therapy Hematopoietic Stem Cells Therapies
Current Stem Cell Research & Therapy DNAJ Proteins and Protein Aggregation Diseases
Current Topics in Medicinal Chemistry Synthesis and Antiacetylcholinesterase Activity Evaluation of New 2-aryl Benzofuran Derivatives
Letters in Drug Design & Discovery The Role of Chemokines in Alzheimer's Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Common Variants in Toll-Like Receptor 4 Confer Susceptibility to Alzheimer’s Disease in a Han Chinese Population
Current Alzheimer Research Unraveling the Complexity of Amyotrophic Lateral Sclerosis: Recent Advances from the Transgenic Mutant SOD1 Mice
CNS & Neurological Disorders - Drug Targets Genetically Engineered Stem Cells for Therapeutic Gene Delivery
Current Gene Therapy Characterization of Adipose-Derived Stem Cells: An Update
Current Stem Cell Research & Therapy